nile blue has been researched along with Acute Lymphoid Leukemia in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Astilean, S; Berindan-Neagoe, I; Boca, S; Cialla-May, D; Florea, A; Jurj, A; Popp, J; Tatar, AS; Tomuleasa, C | 1 |
1 other study(ies) available for nile blue and Acute Lymphoid Leukemia
| Article | Year |
|---|---|
CD19-targeted, Raman tagged gold nanourchins as theranostic agents against acute lymphoblastic leukemia.
Topics: Antigens, CD19; Antineoplastic Agents; Apoptosis; Cell Cycle Checkpoints; Cell Line, Tumor; Gold; Humans; Immunoconjugates; Immunotherapy; Metal Nanoparticles; Microscopy, Electron, Transmission; Oxazines; Polyethylene Glycols; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Spectrum Analysis, Raman | 2019 |